The QualityStocks Daily Stock List
- Firstgroup plc (FGROY)
- eWellness Healthcare Corp. (EWLL)
- Atico Mining Corporation (ATCMF)
- Orocobre Limited (OROCF)
- EOS, Inc. (EOSS)
- Real Goods Solar, Inc. (RGSE)
- Zynex, Inc. (ZYXI)
- BioVie, Inc. (BIVI)
- Patriot Gold Corp. (PGOL)
- Uniroyal Global Engineered Products, Inc. (UNIR)
- Optex Systems Holdings, Inc. (OPXS)
- CanAlaska Uranium Ltd. (CVVUF)
- Alpine 4 Technologies Ltd. (ALPP)
Firstgroup plc (FGROY)
Zacks, OTC Research, Amigo Bulls, Proactive Investors, OTC Markets, The Street, Marketbeat, TradingView, Investors Hangout, InvestorPoint, Wallmine, GuruFocus, Investing.com, Penny Stock Tweets, 4-Traders, Stockhouse, Wallet Investor, YCharts, Barchart, Dividend Investor and MoneyHub reported on Firstgroup plc (FGROY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Incorporated in 1995, Firstgroup plc provides passenger transport services. The Company has extensive experience in the United Kingdom bus and rail markets, and in the student transportation, transit and intercity coach markets in North America. Each of its businesses has a market-leading position in a sector that is key to boosting economic growth and vital to creating strong and sustainable
communities. Firstgroup lists on the OTC Markets and the Company has its head office in London, England.
Firstgroup serves a large range of passengers in the United Kingdom and North America. In addition, the Company works with national governments, state and local authorities, school boards and universities to meet their transport requirements.
Firstgroup has 100,000 employees across the Group and it carries 2.1 billion passengers a year. The Company operates, manages or maintains combined fleets of 50,000 vehicles. Firstgroup has five divisions.
The Company’s Greyhound is the only national operator of scheduled intercity coach services in North America. Greyhound serves 17 million passengers a year. Greyhound has 1,600 vehicles in its fleet.
Moreover, Firstgroup’s First Bus is one of the largest bus operators in the United Kingdom. First Bus serves towns and cities across the country. First Bus has 5,800 buses and serves 1.6 million passengers per day.
First Rail is one of the United Kingdom’s most experienced rail operators. It runs every kind of service from Cornwall to Scotland. First Rail operates more than 400 stations. It operates three United Kingdom rail franchises - Great Western Railway, South Western Railway and TransPennine Express. It also operates one open access passenger rail service, Hull Trains. Furthermore, it operates the London Trams service on behalf of Transport for London.
The Company’s First Student is the largest provider of student transportation in North America. First Student has greater than 460 operating locations throughout the United States and Canada. It engages in five million student journeys per school day.
The Company’s First Transit is one of the largest private sector providers of public transit management and contracting in North America. First Transit has over 310 operating locations throughout the United States and Canada. It owns or operates greater than 12,600 vehicles and maintains a further 35,000.
Firstgroup plc (FGROY), closed Tuesday's trading session at $1.227, up 10.54%, on 1,400 volume with 1 trade. The average volume for the last 60 days is 1,121 and the stock's 52-week low/high is $1.08/$1.74.
eWellness Healthcare Corp. (EWLL)
StockHideout and Penny Stock Prodigy reported previously on eWellness Healthcare Corp. (EWLL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients through contracted physician practices and healthcare systems. eWellness Healthcare is headquartered in Culver City, California.
The Company has launched PHZIO. The design of this Physical Therapy Telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine company to provide insurance reimbursable real-time distance monitored treatments.
eWellness Healthcare’s business model is to license the PHZIO platform to any Physical Therapy (PT) clinic in the U.S. and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO extends a traditional practice online.
The main features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. Furthermore, main features include integrated billing, patient metrics, as well as user administration & customization.
PHZIO also scales a practice’s billable rates. In addition, it provides tools to make growing a business easier.
Regarding the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. It is also a complete on-line PT telemedicine intervention system.
Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.
This past October, eWellness Healthcare announced the launch of its new patient lead generation platform, LeadRemedy.com. Lead Remedy increases a Practices’ social networks reach through tapping in to the employees of the practice and their social circles.
Each week, relevant physical therapy content is sent to practice employees to review and share. Upon a prospective patient viewing the content, the Practice’s brand is always present; the patient can book an evaluation appointment directly from the viewing page.
Mr. Darwin Fogt, eWellness Healthcare Chief Executive Officer, stated, “Physical Therapy Clinics are continually seeking to attract new patients in order to grow and maintain the success of their Practices. Traditionally, this is done through doctor referrals, word of mouth or advertising. Few practices use social media content to attract new patients. Typically, this lack of social media presence is due to the Practice Owners not having the capacity or capability to produce the content needed to be relevant to prospective patients. Practices that sign up for our Lead Remedy Service solve this outreach problem”.
eWellness Healthcare Corp. (EWLL), closed Tuesday's trading session at $0.073, up 21.67%, on 517,173 volume with 45 trades. The average volume for the last 60 days is 487,367 and the stock's 52-week low/high is $0.05/$0.1925.
Atico Mining Corporation (ATCMF)
Junior Mining Network, OTC Markets, 4-Traders, Stockhouse, MarketWatch, InvestorsHub, Marketwired, Streetwise Reports, Investing News, Capital Cube, Barchart, The Street, and The Northern Miner reported on Atico Mining Corporation (ATCMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Atico Mining Corporation centers on exploring, developing, and mining copper and gold projects in Latin America. It focuses on developing and operating high margin midsized Cu-Au deposits. The Company has a proven team of mine developers and mine operators. Its main project is the El Roble mine in Colombia. Atico Mining is based in Vancouver, British Columbia.
The Company is in production and producing cash flow at the El Roble mine. El Roble is in Carmen De Atrato, Colombia. The deposit type is Mafic-Type Volcanic Massive Sulphide. Atico’s ownership of El Roble is 90 percent of the operating mine and surrounding claims.
El Roble is a 6,679-hectare project. It is a producing mine with an 800 Tonnes per day throughput capacity. The end product is CU (+AU, AG) concentrate.
Recent evaluations by Atico Mining identified high-grade mineralization below the lowest production levels at El Roble. These evaluations also defined a measured and indicated resource of 1.86 million tonnes grading 3.46 percent copper and 2.27 g/t gold.
In July, Atico Mining announced the completion of two IP-DAS surveys covering the area from northwestern Archie prospect through the mine to the southern Estrella target area that have indicated new exploration targets near and below the mine.
Mr. Fernando E. Ganoza, Atico Mining Chief Executive Officer, said: "The exploration work and drilling we have completed since late 2017 have returned encouraging results for the occurrence of massive sulphide mineralization at the El Roble property. These results confirm the need to continue drill testing the anomalous targets and merits scaling-up the drill program for the remainder of the year. We continue to believe the property remains highly prospective to host additional massive sulphide mineralization."
Recently, Atico Mining announced its operating results for the three months ended June 30, 2018 from its El Roble mine. Production for the quarter totaled 5.22 million pounds of copper and 2,596 ounces of gold in concentrates. This represents an increase of 1 percent for both copper and gold, respectively, over the same period the year prior.
Atico Mining Corporation (ATCMF), closed Tuesday's trading session at $0.334, up 3.69%, on 4,096 volume with 8 trades. The average volume for the last 60 days is 22,475 and the stock's 52-week low/high is $0.3047/$0.713.
Orocobre Limited (OROCF)
MarketWatch, Bloomberg, Stockhouse, InvestorsHub, Barchart, TipRanks, 4-Traders, CapitalCube, Barron’s, Zacks, GuruFocus, InvestorsHangout, Morningstar, WeeklyHub, MoneyHub, and JuniorMiningNetwork.com reported on Orocobre Limited (OROCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Orocobre Limited is a foremost lithium chemicals producer. The Company is an international lithium carbonate supplier and an established producer of boron. Orocobre is based in Brisbane, Australia and it also has an office in Argentina. Orocobre’s shares trade on the OTC Markets Group’s OTCQB.
The Company’s flagship operation is Salar de Olaroz. The first sale of lithium carbonate from the Olaroz Lithium Facility took place in late April of 2015. Volumes have been growing since then. The Olaroz Lithium Facility is in Northern Argentina.
The Company hosts a JORC/NI 43-101 compliant, high quality, low-cost and long life resource. The measured and indicated resource of 6.4 Mt LCE can sustain a current continuous production for 40-plus years with only approximately 15 percent of the defined resource extracted.
Orocobre is building a considerable Argentine based industrial chemicals company via its portfolio of lithium, potash, as well as boron assets. Borax Argentina is an established Argentine boron minerals and refined chemicals producer. Orocobre acquired Borax Argentina S.A. in August of 2012 from Rio Tinto PLC.
Orocobre’s operations also include a 33 percent interest in Advantage Lithium Corp. based in Vancouver, British Columbia. Advantage Lithium is a resource business. It specializes in the strategic acquisition, exploration and development of lithium properties.
Orocobre entered into a joint venture (JV) agreement with Advantage Lithium in November of 2016 on its Cauchari Project and several exploration projects. With this agreement, Orocobre divested a number of its lithium brine exploration projects, which were held by way of its Argentine subsidiary South American Salars SA (SAS), to Advantage Lithium for a 35 percent share off Advantage.
The Cauchari project is a 50/50 joint venture between Orocobre and Advantage Lithium. Advantage Lithium is increasing its interest in the project from the present 50 percent to 75 percent via the expenditure of US$5M or by completing a Feasibility Study (FS). The remaining interest is held by Orocobre.
Currently, the Cauchari project contains an inferred resource of roughly 470,000 tonnes lithium carbonate equivalent and 1.6 million tonnes of potash.
Regarding Phase 1 drilling, a five hole rotary drill program started in May of last year. Phase 2 drilling will center on potential extensions of the existing inferred resource at Cauchari and exploration where no prior drilling has taken place.
In partnership with Toyota Tsusho Corporation (TTC) and JEMSE, the Company has constructed, and is now operating, the globe’s first commercial, brine-based lithium operation built in approximately 20 years. Orocobre is a leading company in Argentina's “Lithium Triangle”.
Orocobre Limited (OROCF), closed Tuesday's trading session at $3.054, up 1.80%, on 37,644 volume with 85 trades. The average volume for the last 60 days is 37,521 and the stock's 52-week low/high is $2.42/$5.99.
EOS, Inc. (EOSS)
Wolf Street, Dividend Investor, MarketWatch, Stockopedia, Wallet Investor, Real Investment Advice, Barchart, OTC Markets, Stockhouse, InvestorsHub, 4-Traders, The Street, and Trading View reported on EOS, Inc. (EOSS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
EOS, Inc. has an extensive distribution network of associates with manifold dealer companies providing health care, beauty care, and also environmentally friendly cleaning products in Asia. Since Q1 of 2017, the Company has expanded its marketing channels in China and Southeast Asian countries.
EOS is based in Taipei, Taiwan. Formed in 2015, the Company lists on the OTC Markets Group’s OTCQB.
EOS focuses on the marketing and distribution of skin care products to resellers in Taiwan. The Company engages in the distribution and marketing of skin care products manufactured by A.C. (USA), Inc.
EOS’ products include moisturizers, serums, cleansers, and toners. Products also include exfoliators, acne and oil correctors, facial masks, cleansing devices, and sun care products.
On April 22, 2017, Mr. Ben Yang, the chief representative of Asian market, EOS, Inc., signed agency contracts in Nanning City, Guangxi, China, with three owners of new flagship stores launched there. There are four flagship stores set up in China. This includes the first one in Quanzhou. This will help contribute to increasing the business of EOS in China. Nanning City is the largest economy of Guangxi province.
On April 25, 2017, the EOS Singapore flagship store celebrated its grand opening. After the flagship stores opened in Singapore, the associate EOS sales teams in Malaysia, Indonesia, Thailand, and Cambodia are making aggressive moves.
Effective on May 3, 2017, EOS acquired all the issued and outstanding shares of Emperor Star International Trade Co. Ltd. This is the trading team that plays a vital part in the supply chain of EOS products.
EOS acquired Emperor Star trading company in Taipei, Taiwan to strengthen its business and prepare for the challenge of OBOR (One Belt and One Road) development in Malaysia, Indonesia, Thailand, and Cambodia.
Incorporated in Taiwan in November 2015, Emperor Star has been distributing highly unique health and beauty care products and environmentally friendly cleaning products, with first-rate growth in China and Asia.
Recently, EOS announced that Linna Chi joined the Company as its new Chief Senior Consultant, effective July 18, 2018. Chi joins EOS from Soon Mining Limited, where she was the Chief Financial Officer (CFO). In her role as CFO at SMG, she managed corporate finance, treasury, accounting, investor relations, internal audits and risk management.
In addition, she is currently the Director of Kirin International Limited and Kirin International Management Consultants Limited (Taiwan) and Hu Chi Consulting (Shanghai) Company Ltd.
EOS, Inc. (EOSS), closed Tuesday's trading session at $2.40, up 21.83%, on 1,140 volume with 10 trades. The average volume for the last 60 days is 179 and the stock's 52-week low/high is $0.4181/$2.50.
Real Goods Solar, Inc. (RGSE)
InvestorsHub, Investor Place, Stock News Gazette, Stock Twits, MarketWatch, Barchart, and TradingView reported on Real Goods Solar, Inc. (RGSE), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Real Goods Solar, Inc.’s RGS Energy operates as a residential and small business commercial solar energy engineering, procurement, and construction company in the United States. The Company has installed greater than 25,000 solar energy systems for homes, businesses, schools, government facilities, and utilities throughout the nation. This has totaled over 260 megawatts of clean energy. Real Goods Solar (RGS Energy) is based in Denver, Colorado. RGS Energy is the Company’s registered trade name.
Additionally, the Company is the exclusive manufacturer of POWERHOUSE™. This is an inventive in-roof solar shingle utilizing technology developed by The Dow Chemical Company. RGS Energy entered into an exclusive domestic and worldwide license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system. RGS will lead all commercial activities for the product. This includes supply chain management, marketing, sales, installation, as well as warranty.
This solar shingle system has been installed on greater than 1,000 homes. RGS Energy and Dow Chemical anticipate UL product certification during Q1 of 2018. Pre-orders are being taken in advance of final written certification. RGS Energy’s plan is to begin sales and installation of POWERHOUSE™ 3.0 solar shingles immediately after.
Regarding RGS Energy’s business segments, the Solar Division consists of RGS Energy’s Residential and Sunetric business segments. The Corporate segment includes administrative costs associated with administrative services, legal settlements, legal, information systems, and accounting and finance. Beginning on September 29, 2017, POWERHOUSE™ is the Company’s new business segment.
This past November, RGS Energy announced the on-time launch of Solar 365™. This is the Company’s new mobile software and online dashboard suite. New and prospective customers can easily navigate Solar 365™. They can access information and documents concerning their planned solar installation wherever and whenever it is convenient. After installation, customers can easily access and view their cost savings and production stats in kilowatts and dollars earned if net metering.
In 2017, RGS Energy was chosen as exclusive installer for the Solarize Cranston, Solarize Granby, Solarize New Haven and Solarize North Haven communities.
For 2018, RGS Energy expects to attain UL Certification during Q3 and commence sales and installation of POWERHOUSE™ 3.0 solar shingles afterwards. Regarding its Solar Division, RGS Energy expects to realize break-even revenue, apart from POWERHOUSE™, in Q3.
Real Goods Solar, Inc. (RGSE), closed Tuesday's trading session at $0.3649, up 7.48%, on 2,168,425 volume with 2,504 trades. The average volume for the last 60 days is 2,313,477 and the stock's 52-week low/high is $0.30/$3.25.
Zynex, Inc. (ZYXI)
SmallCapVoice, SmarTrend Newsletters, FeedBlitz, Zacks, BUYINS.NET, FNNO Newsletters, Daily Markets, and TaglichBrothers reported earlier on Zynex, Inc. (ZYXI), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Zynex, Inc. is a medical technology company listed on the OTCQB. It specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. In addition, the Company is developing a new blood volume monitor (non-invasive Blood Volume Monitor, CM-1500) for use in hospitals and surgery centers. Established in 1996, Zynex has its head office in Englewood, Colorado.
The Company’s product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold internationally. Zynex engineers, manufactures, markets, and sells its own design of medical devices in three subsidiaries.
Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets.
Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. It also markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.
Zynex believes that its non-invasive Blood Volume Monitor, CM-1500, will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.
New products Zynex has added include JetStream Hot/Cold Therapy, Aspen LSO Backbracing and Comfortrac cervical traction. All of these products are targeted at treating acute and chronic pain without side-effects.
Last month, Zynex announced the introduction of the NeuroMove device into the Company’s expanding direct sales force in the United States market. The design of the NeuroMove™ device is to aid stroke survivors in regaining movement using the brain's ability to rewire itself, also known as "neuro-plasticity".
Mr. Thomas Sandgaard, Founder and Chief Executive Officer, said, "I am excited to announce that we are re-launching the NeuroMove 900 stroke and traumatic brain injury rehabilitation product to our sales force over the next couple of months. We have for many years sold the NeuroMove device primarily to rehabilitation clinics in the US as well as internationally and while the device is designed with home use in mind we have not previously promoted it through our direct sales force. The NeuroMove 900 is a complimentary product for a large portion of our direct sales force aimed at the rehabilitation market.
At the end of February, Zynex reported financial results for its Q4 ended December 31, 2017. Revenue increased 178 percent year over year to $8.1 million. Net Income of $3.3 million grew 1,482 percent year over year.
Moreover, Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $3.9 million grew 481 percent year over year. Zynex produced $8.3 million of Cash from Operations during 2017. This represents an increase of 367 percent versus $1.8 million in 2016. As of December 31, 2017, Zynex had Working Capital of $4.4 million versus a deficit of $4.3 million at December 31, 2016.
Zynex, Inc. (ZYXI), closed Tuesday's trading session at $2.90, up 0.35%, on 64,308 volume with 49 trades. The average volume for the last 60 days is 30,896 and the stock's 52-week low/high is $1.00/$5.50.
BioVie, Inc. (BIVI)
Wealth Insider Alert reported previously on BioVie, Inc. (BIVI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
BioVie, Inc. focuses on the discovery, development, and commercialization of inventive drug therapies for liver disease. Currently, the clinical-stage Company is concentrating on commercializing BIV201. This is a novel approach to the treatment of ascites due to chronic liver cirrhosis. BioVie has its corporate headquarters in Beverly, Massachusetts. The Company’s shares trade on the OTCQB.
BIV201 is a continuous infusion of the peptide terlipressin, first undergoing development for the treatment of refractory ascites. Terlipressin, dosed differently, is approved in approximately 40 nations for other complications of liver cirrhosis coming up from a similar disease pathway. Terlipressin is not available in the United States.
BioVie states that BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, NASH, and alcoholism. The US Patent and Trademark Office (USPTO) issued US Patent No. 9,655,945 covering the Company’s new drug candidate BIV201.
BIV201 has Orphan Drug designation for the most common of these complications, ascites, which represents a major unmet medical need. The FDA has never approved any drug specifically for treating ascites. In addition to patient suffering, U.S. treatment costs for liver cirrhosis, including ascites and other complications, are estimated at over $4 billion per year.
In April 2017, BioVie announced that it received notice from the FDA that the planned Phase 2a clinical trial of its new drug candidate BIV201 may begin. This was based on BioVie’s IND to conduct a study in patients with refractory or intractable ascites due to advanced liver cirrhosis.
Furthermore, the Company was notified by the USPTO that its application for a core patent covering the use of BIV201 to lessen ascites formation in ambulatory patients was authorized.
Additionally, BioVie announced in April 2017 the signing of a Cooperative Research and Development Agreement (CRADA). This is to conduct a Phase 2a clinical trial of BIV201 in patients with refractory or intractable ascites because of advanced liver cirrhosis.
In November 2017, BioVie reported that a second patient was dosed with the Orphan drug candidate BIV201 (continuous infusion terlipressin) in a mid-stage Phase 2a clinical trial of patients suffering from refractory ascites due to advanced liver cirrhosis. The design of the study is to evaluate 6 patients with refractory ascites. In October 2017, the first patient completed 28 days of treatment with BIV201 and entered the post-therapy observational period.
This past December, BioVie announced that the FDA granted Fast Track designation for BIV201 (continuous infusion terlipressin), the Company's patented Orphan drug candidate. BIV201 is now undergoing evaluation for the treatment of refractory ascites due to liver cirrhosis in a mid-stage (Phase 2a) US clinical trial, with two of the planned six patients having been treated with this therapy so far. The results for all six refractory ascites patients planned for the Company’s Phase 2a clinical trial of BIV201 are expected by Q2 of 2018.
BioVie, Inc. (BIVI), closed Tuesday's trading session at $0.1325, up 1.92%, on 42,403 volume with 9 trades. The average volume for the last 60 days is 152,457 and the stock's 52-week low/high is $0.012/$0.35.
Patriot Gold Corp. (PGOL)
OtcWizard, Gold Investment Letter, Real Pennies, and Standout Stocks reported previously on Patriot Gold Corp. (PGOL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Patriot Gold Corp. is a precious metals exploration and production company. Its mission is to discover and develop significant gold and silver assets in the States of Arizona and Nevada. At present, the Company holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold has its corporate office in Las Vegas, Nevada.
The Company holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Vernal and Windy Peak projects in Nevada.
The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and around 70 miles southeast of Las Vegas. The Moss Mine is owned by Northern Vertex Mining Corp.
The Bruner gold project property is roughly 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine. Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project is owned by Canamex Resources Corp.
The Windy Peak Gold Project consists of 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is approximately 45 miles southeast of Fallon and 6 miles from Middlegate.
The Vernal gold project is in its early stage. The property is approximately 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. The property consists of 12 unpatented mining claims (240 acres).
The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts numerous major deposits. These include the Goldfield (greater than 5 million ounces of post production and present reserves) and the Comstock (greater than 8 million ounces).
Last month, Patriot Gold reported that the Moss Mine, owned by Northern Vertex Mining, is quickly advancing toward the pouring of its initial commercial gold/silver dore bars, according to a recent announcement by Northern Vertex. Northern Vertex Mining announced that around 7,800 tons of ore were stacked on the pad so far.
Northern Vertex is moving towards an initial stacking rate of 2,500 tpd, and subsequently to 5,000 tpd. Additionally, it reported that all of the crushing plant components were tested and commissioned, piping on the heap leach pad started, and the refinery furnace was to be commissioned.
In addition, in February, Patriot Gold announced that permitting is in place for its 2018 drilling program on its Windy Peak gold project in Nevada. The Company has identified a number of drilling targets. Patriot is in the process of choosing a drilling contractor.
Patriot Gold Corp. (PGOL), closed Tuesday's trading session at $0.0632, up 0.08%, on 7,996 volume with 2 trades. The average volume for the last 60 days is 16,985 and the stock's 52-week low/high is $0.0438/$0.11.
Uniroyal Global Engineered Products, Inc. (UNIR)
NetworkNewsWire, Proactive Investors, Zacks, 4-Traders, Morningstar, MarketWatch, Zacks, Stockhouse, Real Investment Advice and Marketbeat reported on Uniroyal Global Engineered Products, Inc. (UNIR), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Uniroyal Global Engineered Products, Inc., by way of its subsidiaries, is a foremost manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. Established in 1992; Uniroyal Global Engineered Products (UNIR) is based in Sarasota, Florida.
The Company’s chief brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. In addition, UNIR’s brand names include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.
UNIR is a leading supplier of vinyl coated fabric materials for the automotive and commercial industries. Its products in the automotive industry are used mainly in seating, door panels, head and arm rests, security shades, and trim components.
UNIR’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.
In 2017, UNIR’s Revenue was derived 67.5 percent from the automotive industry and roughly 32.5 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality and health care markets.
The Company’s Naugahyde brand introduced Casablanca in 2016. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®. All of Casablanca’s patterns are flame retardant, stain resistant, and anti-microbial.
Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish. This collection was developed with hospitality, contract, marine, as well as healthcare markets in mind.
Last month, UNIR announced that its subsidiary, Uniroyal Engineered Products, LLC attained IATF 16949:2016 certification. This is the highest global quality standard for the automotive industry. This certification encompasses UNIR’s Stoughton, Wisconsin plant, R&D lab and test facility. Additionally, its Stoughton facility holds the ISO 9001:2015 certification.
Last week, UNIR reported its financial results for Q2 and six months ended July 1, 2018. Net Sales were in line with the previous year on increases in the Automotive Sector. Gross Profit margins improved quarter-to-quarter on operational improvements, cost reduction and increased selling prices.
Operating expenses declined to 12.6 percent of Net Sales in comparison to 14.2 percent in the previous year quarter. Net Income Available to Common Shareholders was $148,389 or $0.01 per share, in line with the previous year.
Uniroyal Global Engineered Products, Inc. (UNIR), closed Tuesday's trading session at $1.56, up 15.56%, on 140 volume with 2 trades. The average volume for the last 60 days is 1,125 and the stock's 52-week low/high is $1.00/$3.20.
Optex Systems Holdings, Inc. (OPXS)
OTCMagic, Damn Good Penny Picks, Penny Picks, PennyStockLocks, Prepump Stocks, StockRockandRoll, Stock Beast, Penny Stock Newsletter, Stock Commander, MicroCapDaily, Epic Stock Picks, Wolf of Penny Stocks, DSR News, DamnGoodPennyStock, PHUB News, William Velmer, and S.A. Advisory reported on Optex Systems Holdings, Inc. (OPXS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Optex Systems Holdings, Inc. is a top manufacturer of optical sighting systems and assemblies, chiefly for Department of Defense (DoD) applications. In addition, the Company manufactures and delivers multiple periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Optex delivers its products directly to the military services and to prime contractors. OTCQB-listed, Optex Systems Holdings has its corporate office in Richardson, Texas.
Optex Systems, Inc. is a wholly-owned subsidiary of Optex Systems Holdings. Optex Systems Holdings reported in November 2014 the completion of the acquisition of the Applied Optics Center (AOC) Division of Warrior Systems Sector with the Electronics Systems Business Segment of L-3 Communications Corp.
Optex Systems’ products are installed on diverse kinds of U.S. military land vehicles. These include the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles. Additionally, the Company’s products have been chosen for installation on the Stryker family of vehicles.
Optex Systems manufactures the US Navy 20x 120mm Ship Binoculars. Moreover, the Company brings creative technology to vehicular mounted sighting systems. Its dismounted sighting systems work on weapon sights, night vision goggles, and any other sighting requirements outside of ships and land vehicles. Furthermore, Optex Systems can meet commercial (non-military) requirements.
Optex Systems, Inc. announced this past March that it was awarded $1.62 million as part of a multi-year strategic supplier agreement with a domestic manufacturer of first-class optical devices. The products will be manufactured at the Applied Optics Center (AOC) Division of Optex Systems, Inc. AOC is a vital supplier of technically challenging thin-film coatings, optical components, assemblies and systems.
Yesterday, Optex Systems Holdings announced financial highlights from its Q2 2018 financial results. During the three and nine months ending July 1, 2018, the Company has experienced considerable Revenue growth of 41.9 percent and 30.3 percent, respectively, versus the three and nine months ending July 2, 2017.
It also experienced improvements in Gross Margin percentages of 4.2 percent and 3.0 percent and reductions in its General and Administrative Expenses of 5.8 percent and 6.9 percent, respectively, versus the three and nine months ending July 2, 2017.
During the first three quarters of fiscal year 2018, Optex Systems’ Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is up 449.2 percent from the prior year level. The Company’s backlog is up 24.2 percent from October 1, 2017.
Optex Systems Holdings, Inc. (OPXS), closed Tuesday's trading session at $1.42, up 31.48%, on 513,081 volume with 467 trades. The average volume for the last 60 days is 41,145 and the stock's 52-week low/high is $0.871/$1.31.
CanAlaska Uranium Ltd. (CVVUF)
Streetwise Reports, OTC Markets Group, InvestorsHub, Resource World, Dividend Investor, Morningstar, Stockhouse, and FeedBlitz reported on CanAlaska Uranium Ltd. (CVVUF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CanAlaska Uranium Ltd. is an exploration stage enterprise listed on the OTCQB. The Company focuses on two key projects in the Athabasca Basin in Saskatchewan. A project generator, CanAlaska Uranium is based in Vancouver, British Columbia.
CanAlaska Uranium holds interests in roughly 102,870 hectares (254,000 acres), one of the largest land positions in Canada's Athabasca Basin region. Its strategic holdings have attracted major global mining companies. Currently, CanAlaska is working with Cameco and Denison at two of CanAlaska’s properties in the Eastern Athabasca Basin.
The Company’s projects include Cree East, West McArthur, NW Manitoba, and base metals and gold projects and other uranium projects and its diamond projects. The Cree East project is a high-priority property situated in the south-eastern portion of the Athabasca Basin.
The West McArthur project is contiguous to the world’s richest uranium mine -Cameco's McArthur River. The objective at West McArthur is a large unconformity uranium deposit. Moreover, $20 million of work successfully identified seven target areas.
CanAlaska Uranium’s NW Manitoba project lies in northwest Manitoba just east of the border of northeast Saskatchewan. It is 70 kilometers north of Reindeer Lake.
The Company has new targets developed at the Thompson Nickel Belt Properties. In Manitoba, CanAlaska Uranium has continued Project Generation activities, with licence acquisitions in the Thompson Nickel Belt. Compilation work has continued. More targets have been developed on the Strong and Hunter properties.
CanAlaska Uranium also acquired four new claims groups in the western Athabasca Basin for diamond exploration. Three of these are in the region just north of current claims in the Patterson Lake area.
Last month, CanAlaska Uranium announced being able to model historical drill data and define a 400 meter long high-grade nickel target within a 1,200 meter long horizon of semi-continuous nickel mineralization, north of the former producing Manibridge nickel mine, in the Thompson Nickel Belt, Manitoba.
CanAlaska President, Mr. Peter Dasler, said in July, "CanAlaska now has three large projects in the Thompson Nickel Belt. The Manibridge target shows a significant concentration of high grade nickel within a broad fold structure that appears to extend to depth. Our compilation work shows additional structural targets associated with high geophysical response from the historical VTEM and GEOTEM surveys. We will be gathering additional data on these targets with a planned airborne survey, with the expectation of outlining additional drill targets."
CanAlaska Uranium Ltd. (CVVUF), closed Tuesday's trading session at $0.215, down 5.08%, on 32,475 volume with 13 trades. The average volume for the last 60 days is 20,394 and the stock's 52-week low/high is $0.2081/$0.37.
Alpine 4 Technologies Ltd. (ALPP)
TradingView, InvestorsHub, OTC Markets, Stockhouse, and MarketWatch reported on Alpine 4 Technologies Ltd. (ALPP), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Alpine 4 Technologies Ltd. is a technology and manufacturing holding company headquartered in Phoenix, Arizona. It has business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Data Technologies. The Company previously went by the name Alpine 4 Automotive Technologies Ltd. It changed its corporate name to Alpine 4 Technologies Ltd. in June of 2015. Established in 2014, Alpine 4 Technologies lists on the OTC Markets’ OTCQB.
Alpine 4’s emphasis is on how the adaptation of new technologies, even in brick and mortar businesses, can propel innovation. The heart of its acquisition strategy is its focus on existing smaller middle market operating companies with Revenues of $5 to $50 million.
The design of Alpine 4 Technologies is to allow its subsidiaries room to develop their own identities and synergistically prosper from inter-company resources and collaboration. Alpine 4 will own controlling interest in every subsidiary. In addition, it will have direct control over planning and management.
The Company’s subsidiaries and product groups include ALTIA; Quality Circuit Assembly (QCA); and Venture West Energy Services. ALTIA is an automotive products company. The Quality Circuit Assembly (QCA) subsidiary provides electronic contract manufacturing solutions delivered to its customers by way of strategic business partnerships. Venture West Energy Services concentrates on supporting the oil and gas industry in Texas, Oklahoma, and Arkansas.
Alpine 4 Technologies has started two pilots of SPECTRUMebos, a blockchain Enterprise Business Operating System, in its subsidiaries Quality Circuit Assembly (QCA) and ALTIA, LLC. SPECTRUMebos is an Enterprise Business Operating System (EBOS) developed by Alpine 4 Technologies.
SPECTRUMebos combines the key technology software mechanisms of Accounting and Financial Reporting of an Enterprise Resource Planning System (ERP), a Document Management System (DMS), a Business Intelligence (BI) platform and a Customer Resource Management (CRM) hub all tied to a management reporting and collaboration toolset.
Alpine 4 Technologies completed its acquisition of American Precision Fabricators, Inc. (APF) in 2018. The acquisition adds to Alpine 4’s technology manufacturing sector play, which began in 2016 with its purchase of Quality Circuit Assembly (QCA). This is the fourth acquisition that Alpine 4 Technologies has made in two years.
For greater than two decades, APF has been an industry leader for customers in the OEM (original equipment manufacturing) markets, fabricating and manufacturing components and products for many Fortune 1000 customers.
Recently, Alpine 4 Technologies’ subsidiary, Quality Circuit Assembly (QCA), announced a manufacturing partnership with Cobalt Robotics. The addition of customers such as Cobalt fits the QCA strategy and will help boost 2018 revenue.
In 2016, Mr. Travis Deyle and Mr. Erik Schluntz founded Cobalt Robotics (San Mateo, California). Cobalt Robotics fills a gap in the spectrum of security solutions via its highly-trained remote Specialists and fleet of autonomous robots.
Alpine 4 Technologies Ltd. (ALPP), closed Tuesday's trading session at $0.075, even for the day. The average volume for the last 60 days is 27,066 and the stock's 52-week low/high is $0.0502/$0.64.
The QualityStocks Company Corner
- Aftermaster, Inc. (OTCQB: AFTM)
- Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)
- ChineseInvestors.com (OTCQB: CIIX)
- FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)
- Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF)
- Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF)
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)
- Accelerated Technologies Holding Corp. (OTC: ATHC)
- Pacific Software, Inc. (OTC: PFSF)
- Earth Science Tech, Inc. (OTC: ETST)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF)
- Cannabis Strategic Ventures, Inc. (OTC: NUGS)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
Aftermaster, Inc. (OTCQB: AFTM)
Aftermaster, Inc. (OTCQB: AFTM) an award-winning, industry leading audio company, today announced it will hold a conference call to provide investors with a Company update. The call is scheduled for Tuesday, August 21, 2018 at 1:00 PM PT and will be hosted by Aftermaster Chairman and CEO Larry Ryckman. Date, Time: Tuesday, August 21, 2018, 1:00 PM PDT; Toll free: (833) 859-8955; Conference ID: 5397923
Aftermaster, Inc. (OTCQB: AFTM), with offices in Scottsdale, Arizona, and Hollywood California, is an award-winning, leading-edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. The company also operates world-class mastering and recording studios located in the heart of Hollywood, California, in the famous Crossroads of the World complex along Sunset Boulevard.
Aftermaster and its subsidiaries are engaged in the development and commercialization of proprietary (patents issued and pending), leading-edge audio and video technologies for professional and consumer use including the award-winning AfterMaster® audio technology, ProMaster™ and Aftermaster Pro™. Aftermaster is unique in the audio world because its team has produced, engineered and mastered more hit records than any audio company in the world. The Aftermaster team knows what sounds right and the Company holds a unique position in the world of audio technology.
The Company’s underlying technology, Aftermaster audio, delivers an audio experience unrivaled by any audio company. It brings an unprecedented new quality level to consumer audio by offering unparalleled clarity, depth, fullness and a significant volume increase to audio recordings without distortion or altering the original recording. Its versatility and smart processing characteristics make it effective across a broad range of applications from consumer electronics to industrial applications.
The Company also operates Aftermaster Recording and Mastering Studios which include the renovated production facilities of legendary director Alfred Hitchcock and the iconic recording studios of Crosby, Stills and Nash.
Aftermaster Labs maintains five primary business units: Aftermaster proprietary semiconductor chip and software for OEM licensing, proprietary consumer electronics, professional music mastering, online mastering, recording and mixing at its Aftermaster Recording and Master Studios, and Audio Consulting services. The Aftermaster semiconductor chip and software is used for embedding in consumer products, Aftermaster-developed and branded consumer and professional electronic products, ProMaster on-line music mastering for independent music artists and in-studio professional music mastering services.
Aftermaster has increasingly attracted interest from some of the music industry’s leading audio companies. A newly expanded partnership with TuneCore, the leading digital music distribution and publishing administration provider, gives TuneCore members access to Promaster through its instant mastering service which offers audio mastering of unparalleled quality at the click of a button. The Company also recently entered into a licensing agreement with Muzik headphones for use of its Aftermaster chip in their new headphone line.
The company’s first groundbreaking consumer product – the Aftermaster Pro – is designed to solve the universally widespread problem of poor, variable audio levels of television audio. Aftermaster Pro, which is smaller than an iPhone, masters and remasters inconsistent TV audio in real-time, creating an audio experience that offers clear, full-bodied depths of sound and most importantly, overall balanced audio. The Aftermaster Pro virtually eliminates the need to adjust TV volume to hear dialogue or to reduce the level of loud special effects. The Aftermaster Pro sells for $179 and is enjoying strong growth in sales to over 65 countries.
With the Company’s Promaster, state-of-the-art proprietary algorithms, artists receive four CD quality mastered versions of their track including “Powerful,” “Radio Ready,” “Bass Enhanced,” and “Vocal Enhanced.” TuneCore artists have access to exclusive pricing on the Promaster pay-as-you-go instant mastering, as well as unlimited monthly and annual subscriptions. Aftermaster also holds a license agreement with headphone manufacturer, Muzik, Inc., for the use of Aftermaster’s patented audio remastering and audio enhancement technology.
Aftermaster won three Envisioneering Innovation and Design Awards at the 2016 Consumer Electronics Show in Las Vegas for both its Aftermaster TV device and its BelaSigna 300 processor semiconductor chip created through a partnership with ON Semiconductor. Aftermaster was also named an honoree for its ProMaster audio technology.
Aftermaster Audio Labs is led by a group of world-class audio engineers and music industry veterans who have been involved with the development and implementation of countless successful proprietary audio technologies and products.
Aftermaster co-founder and CEO Larry Ryckman is an award-winning entertainment and technology executive with over 25 years of achievements in the music and entertainment industries.
Shelly Yakus, co-founder and chief engineer at Aftermaster Audio Labs, is a renowned music producer, audio engineer/mixer and is widely considered the best engineer and mixer in the music industry.
Justin Timberlake, a Grammy and Emmy award-winning singer/songwriter/producer and actor, is a co-owner of Aftermaster Audio Labs, Inc. Timberlake is widely considered to be one of pop culture’s most influential entertainers in the world.
Peter Doell is one of the best-known mastering engineers in the world with over 35 years of experience mastering and engineering hundreds of chart-topping records, film scores and TV spots. Rodney Jerkins is an 8-time Grammy Award winning music producer/songwriter and considered to be one of the most influential and successful producers in the music industry.
Paul Wolff is a senior engineer and product development consultant at Aftermaster Audio Labs. Wolff has been involved in the professional music and audio industries as an audio engineer and product designer and manufacturer of professional audio products for more than 35 years.
Thousands of hours of testing millions of songs and audio sources of all types have been processed using Aftermaster’s award-winning technology and the results speak for themselves with platinum records, numerous strategic partnerships, and overwhelming industry support.
Aftermaster, Inc. (AFTM), closed the day's trading session at $0.04, up 33.33%, on 1,076,305 volume with 27 trades. The average volume for the last 60 days is 361,918 and the stock's 52-week low/high is $0.0255/$0.19.
- Aftermaster, Inc. to Host Shareholder Update Call on August 21, 2018
- NetworkNewsBreaks – Aftermaster, Inc. (AFTM) Masters the Art of Sound
- NetworkNewsBreaks – Aftermaster, Inc. (AFTM) Provides Novice-to-Pro Magic with Disruptive Audio Technology
Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)
Junior exploration company Marifil Mines (TSX.V: MFM) (OTCQB: MFMLF) recently released assay work on the results of new drilling its San Roque property in southwestern Argentina’s Rio Negro province. To view the full article, visit: http://nnw.fm/0NMj2.
Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.
The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.
Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.
The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.
Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.
In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”
To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.
Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.
Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.
Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.0853, up 16.85%, on 125 volume with 1 trade. The average volume for the last 60 days is 2,133 and the stock's 52-week low/high is $0.01/$0.165.
- NetworkNewsBreaks – Marifil Mines Ltd.’s (TSX.V: MFM) (OTCQB: MFMLF) San Roque Property Advances Toward Becoming an Economic Mineral Deposit
- NetworkNewsBreaks – Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Sees Encouraging Future in San Roque Property
- NetworkNewsBreaks – Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Explores Mineral-rich Properties as Potential Global Supply Shortages Approach
ChineseInvestors.com (OTCQB: CIIX)
ChineseInvestors.com (OTCQB: CIIX) this morning announced that on August 18, 2018, its wholly owned subsidiary ChineseHempOil.com, Inc. will be holding a seminar at its flagship retail store, Chinese Wellness Center in San Gabriel, CA. To view the full press release, visit: http://cnw.fm/6ZfDm.
Founded in 1999, ChineseInvestors.com (OTCQB: CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed the day's trading session at $0.795, up 15.07%, on 2,446,111 volume with 1,361 trades. The average volume for the last 60 days is 119,108 and the stock's 52-week low/high is $0.365/$1.58.
- CannabisNewsBreaks – ChineseInvestors.com (CIIX) Subsidiary to Host Seminar on the Health Benefits of Hemp Oil
- ChineseInvestors.com, Inc. Announces its August 18, 2018 Hemp Oil Seminar at its Flagship Retail Store, Chinese Wellness Center, led by Amin Wang, a Chinese Medicine Practitioner
- CryptoNewsBreaks – ChineseInvestors.com (CIIX) Offers 101s and Advanced Courses in Cryptocurrencies
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company focused on becoming the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry, continues to gain momentum as it invests in top-tier cannabis-related companies. FinCanna’s royalty model is a viable capital solution for U.S. businesses in the licensed medical cannabis sector as the company invests capital for a percentage of future revenues. The company also recently announced that it has advanced the initial tranche of capital totaling $1.25 million to its investee company, Refined Resin Technologies Inc.To view the full press release, visit: http://cnw.fm/4XUVy.
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.
Medical Cannabis Market
According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.
Royalty Model & Portfolio
FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.
FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.
CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.
The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.
Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.
FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.
The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.
FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1957, up 9.45%, on 2,497 volume with 5 trades. The average volume for the last 60 days is 46,172 and the stock's 52-week low/high is $0.10/$0.8736.
- CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1.25M Capital Tranche to Refined Resin Technologies
- FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Companies Gain Traction in US Medical Cannabis Space
- CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Announces Advancement of Capital Tranche to ezGreen Compliance
Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8)
Victory Square Technologies Inc. (CSE: VST, OTC: VSQTF, FWB: 6F6) is partnering with the Virtual Reality and Augmented Reality Association (“VRARA”) to host the 2018 VR/AR Global Summit (the “Global Summit”) September 21st and 22nd at the newly-opened Parq Vancouver, a casino, entertainment and hospitality complex situated adjacent to BC Place Stadium in Vancouver.
Victory Square Technologies Inc. (VSQTF) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally.
Victory Square has made multiple early partnerships and investments in the blockchain space. Approximately three years ago the company incubated and invested in BTL Group, which is now a $150 million dollar TSX-listed company offering blockchain solutions across multiple industries with particular focus on the finance, energy and gaming sectors. BTL’s showcase product – Interbit – is a blockchain platform that facilitates the rapid development of business applications that dramatically improve efficiency. Some of the world’s largest institutions are using Interbit to explore new opportunities on private blockchains.
A new social sports betting platform to be developed by Victory Square’s wholly owned subsidiary, FansUnite Media Inc. As a social sports data platform, FansUnite relies on robust data to allow members of its community to engage with like-minded individuals by collaborating, discussing, and predicting the winners of sporting events with a free virtual currency. The integration of blockchain technology into FansUnite’s social sports data platform could also lead to blockchain initiatives developed by other divisions and subsidiaries of Victory Square.
Integral to the FansUnite platform is the introduction of FAN Tokens, an in-game currency purchased with the cryptocurrency Ethereum that token holders can use to place wagers. FansUnite members will be able to earn FAN Tokens through participation in any number of networking effects identified in the company’s Bounty program.
“Blockchain technology and the inherent security it provides will enable us to push every envelope we can to build the most dynamic and responsive social sports betting platform,” said Darius Eghdami, Co-Founder and Chief Executive Officer of FansUnite. “The opportunity to secure data through Blockchain certainly appeals to the accountant in me and we are confident it will become the gold standard among sports betting sites around the world.”
Company subsidiary Victory Square Health Inc., which serves as the venture arm dedicated to companies focused on the development of solutions in personalized health technologies, has also invested in Personalized Biomarkers Inc. (PBI). PBI develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potential biomarkers have been identified, allowing PBI to enter a $4 billion market opportunity.
“We are excited for the opportunity to partner with Personalized Biomarkers as they have correctly identified a massive market opportunity, and have formed an exceptional team of industry leaders,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “This is another investment that is fully aligned with our newly created subsidiary, and one we expect to significantly impact the landscape of personalized medicine.”
A partnership with Insight Diagnostics Inc., also through Victory Square Health, will focus on the development of a personalized diagnostic solution for the improved management and prevention of Type II diabetes.
The company’s investment in V2 Games, a development and publishing studio of high-quality mobile games, is another example of incubating great ideas. V2 Games is well known for its successful launch of PAC-MAN Bounce and Beast Brawlers, two of the company’s releases that are capturing the gaming world by the millions of downloads.
In a move designed to strengthen its presence in film and entertainment, Victory Square has acquired a 40 percent equity stake in United Film Fund II, LLC, which is producing three major motion pictures in 2017 and 2018 including “What They Had,” starring two-time Academy Award winner Hilary Swank.
“This kind of investment in entertainment and film represents a major plank for our Company going forward and we consider ourselves fortunate to have the opportunity to acquire this 40% stake in the Film Fund,” said Tejani, who has launched more than 40 startups in 21 countries that employ hundreds of people and generate more than $100 million in annual revenues. “We believe it’s another strong initiative in film production for us and our stakeholders,” he added.
Victory Square has strategically positioned itself in the legal cannabis industry through an investment in Tantalus Labs, a Canadian-based cannabis cultivation company. Tantalus Labs optimizes plant health and sustainable cultivation by using a unique, environmentally controlled greenhouse engineered specifically for growing cannabis. Called a “SunLab,” the greenhouse takes 90 percent less electricity, uses filtered rainwater, and cools the growing environment to prevent stagnant moisture, recycling the air every 7 minutes to achieve maximum airflow.
Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents. Tejani has pledged to match up to $1 million in donated funds to be shared by a number of Canadian endeavors aimed at education and child-safe projects.
“These are exciting and important steps in the evolution and growth of our Company, and which properly and fully align with our strategic plan focusing on our core competencies in Blockchain Technology, Artificial Intelligence, Gaming, Personalized Health, Film and Virtual, Augmented and Mixed Reality,” said Tejani. “We’re spurred on by the success we have had in building on our original forays into fantasy sports, mobile gaming and immersive sports. In addition, we are energized by our most recent initiatives in sports, personalized health and entertainment and the confidence being shown by our shareholders in the dynamic direction of the Company.”
Victory Square Technologies and its management team believe innovation, incubation of excellent ideas and social responsibility are at the core of its growing success.
Victory Square Technologies Inc. (VSQTF), closed the day's trading session at $0.57, up 8.28%, on 25,425 volume with 15 trades. The average volume for the last 60 days is 18,853 and the stock's 52-week low/high is $0.298/$3.32.
- Victory Square Partners With VR/AR Association to Bring Global Summit to Vancouver
- CryptoNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) CEO to Convert Loans into Common Shares
- Victory Square CEO to Convert Loans Into Common Shares at 19% Premium to Market
Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF)
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Koios Beverage Corp. (CSE:KBEV) (OTC Pink:SNOVF). Koios is a functional food and beverage company focused on cognitive enhancements.
Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.
The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:
- Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
- Vegan-friendly capsules;
- Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.
Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.
According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.
Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.
Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.
Koios contains the following ingredients, among others:
- Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
- Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
- Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
- Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
- Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.
A full breakdown of Koios’ active ingredients is available on the company website.
Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”
The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.
Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.
With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..
Koios Beverage Corp. (SNOVF), closed the day's trading session at $0.162, up 7.81%, on 18,199 volume with 12 trades. The average volume for the last 60 days is 52,191 and the stock's 52-week low/high is $0.001/$0.5121.
- Koios Launches New Products, Expands Distribution & Begins Clinical Trials in the Functional Food & Beverage Space - CFN Media
- Koios introduces first flavour in new line of reformulated drinks
- CFN Media: Koios Expands into Cannabis Functional Beverages
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is pleased to report significant bioavailability results from its randomized and double-blind European human clinical study of DehydraTECH™ powered TurboCBD™ and cannabidiol (CBD) fortified hemp oil capsules (http://cnw.fm/2NCrW). The new study evaluated the speed and degree of CBD absorption into blood plasma and included cardiovascular and cognitive enhancement in male volunteers.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.
The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.
In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.69, up 1.81%, on 81,436 volume with 147 trades. The average volume for the last 60 days is 230,867 and the stock's 52-week low/high is $0.322/$2.54.
- Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study on TurboCBD Capsules Corroborates Earlier DehydraTECH Test Results
- CFN Exclusive Interview: Lexarias DehydraTECH Could Transform the $680 Billion Tobacco Industry -- CFN Media
- CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Successful Delivery of Nicotine Within Minutes in Edible Nicotine Study
Accelerated Technologies Holding Corp. (OTC: ATHC)
NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Accelerated Technologies Holding Corp. (OTC: ATHC), a client of NNW that specializes in cloud-based disruptive technologies. The interview can be heard at http://nnw.fm/a69UF.
Accelerated Technologies Holding Corp. (OTC: ATHC) is a full-service end-to-end business solution and technology company that specializes in cloud-based disruptive technologies. The Company provides consulting and enterprise-level technology services and is developing its own disruptive technology products in the sectors of artificial social realities, short-term alternative funding platforms, electronic payment solutions, and blockchain technologies focused on social engagement, sports, entertainment and content creation.
ATHC is more than a publicly traded company determined to make a buck. Its mission is to create a pioneering business model by taking a leadership position in institutionalizing investment in the regional venture capital market. ATHC’s core values, beliefs and fundamentals revolve around today’s great visionaries – the great leaders of tomorrow. For young entrepreneurs, ATHC offers funding assistance, guidance and investment capital in return for reasonable equity, commitment and an unparalleled work ethic. ATHC and its economies of scale enable the Company to develop technology at reasonable costs while leveraging expertise and contacts for effective execution. The Company intends to create shareholder value by monetizing equity retained by ATHC.
ATHC’s investment domain and expertise lies in consumer Internet, cloud computing and software-as-a-service (Saas), mobile software and services, software-powered consumer electronics, infrastructure and applications software, networking, storage, databases and other backend systems. ATHC’s portfolio to date includes:
- Intelagy – a wholly owned subsidiary of Accelerated Technologies Holding Group, is all about bringing business to businesses. Intelagy provides services that every business’ needs in today’s dynamic and digital marketplace. These services include discounted Merchant Services, Merchant Cash Advances (working capital and loans for businesses), Mobile Processing, Web Design and Hosting solutions, Printing, Local Marketing, Online Marketing, Reputation Management, Prepaid Debit Card Solutions, Payroll Services, and Telecom needs for small, mid-sized and enterprise-level businesses.
- Finbridge Holdings provides capital to alternative lenders with receivables between $2 million and $5 million and to those operating in merchant cash advance and other short-term micro loan environments. Finbridge Holdings’ lending model provides ISOs with an alternative to private placement capital to obtain cash to grow their business. Finbridge intends to be a leader in the loans-to-lender space, primarily focused on those specializing in the small to medium business lending channel.
- XStreamCorp – a Reality Gaming Social Network. XStreamCorp presents an opportunity to penetrate popular social gaming networks by incorporating proprietary technologies that provide users with streaming video, audio and messaging capabilities. These enhancements will dramatically change the player experience in online gaming. Revenue is expected via sales of in-game virtual goods in Social Poker Play formats and events; in-game advertising; and banner advertising around the Company’s gaming portal.
- IconXchange will endeavor to provide a decentralized, open, resilient infrastructure for a new generation of human funding that includes blockchain-based IconXchange Coins and value-based IXC tokens. IconXchange aims to be a platform through which valuable brands are identified, grown, and incentivized. A value-based token enables enhanced liquidity and accelerated funding. IconXchange intends to capitalize on the blockchain’s evolution and improvement without being locked into any one protocol or platform.
ATHC is the destination to discover professionals, guidance, cross marketing opportunities, industry trends, and investments. The Company was built with a unique and scalable approach to collect, leverage and contribute to a strong community of venture capital partners, dynamic sales and marketing verticals, and in-house data teams armed with powerful machine learning, data science, development, management and execution skills. ATHC provides corporate consulting for private and publicly traded companies; technology planning and engineering services; installation and maintenance of cybersecurity resources; and venture capital and financing.
The management team at ATHC is driven, committed, and experienced in building infrastructure for startups. President Kevin H. Kading is the founder, chairman and CEO of Kading Companies S.A. Between 1979 and 1995, he held various positions at Wall Street investment banking firms. Since 1995, he has been a member of Securities Traders Association both nationally and in New York. Kading was a founder, officer, and chairman of the Board of Advanced Reconnaissance Corp. from 1997 to February 2006.
Managing director Alex M. Lemberg has worked as a business analyst on Wall Street since 1992 with the following companies: Merrill Lynch, Morgan Stanley, Barclays Capital, CIBC, Bank of America Securities, and Credit Suisse. He brings a vast understanding of the business process and the use of technologies in order to maintain a streamlined, user-friendly environment.
Accelerated Technologies Holding Corp. (ATHC), closed the day's trading session at $0.546, even for the day, on 200 volume with 1 trade. The average volume for the last 60 days is 2,244 and the stock's 52-week low/high is $0.026/$1.00.
- Accelerated Technologies Holding Corp. (OTC: ATHC) Discusses Fintech Innovation in Exclusive NetworkNewsWire Interview
- Accelerated Technologies Holding Corp. Files Q2 Financials, Provides Business Update
- Accelerated Technologies Holding Corp. Expands Intelagy Operations to Include Credit Card Processing and Business Solutions Operations
Pacific Software, Inc. (OTC: PFSF)
Since the publication of Adam Smith’s ‘The Wealth of Nations’ in 1776, which, among other things, set out the theory of absolute advantage, and David Ricardo’s ‘On the Principles of Political Economy’, published in 1819, which introduced the advantageous subtleties of comparative advantage, no sensible person has sought to deny that international trade has its benefits. In line with that economic theory, accepted by the U.S. Chamber of Commerce, Pacific Software, Inc. (OTC: PFSF) is now out to facilitate global trade (http://nnw.fm/4b3AJ). The company has announced the signing of a definitive agreement to begin construction of its proprietary ecommerce trade platform.
Pacific Software, Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.
The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.
Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.
As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.
Pacific Software, Inc. (PFSF), closed the day's trading session at $5.25, even for the day. The average volume for the last 60 days is 57 and the stock's 52-week low/high is $4.00/$5.25.
- Pacific Software, Inc. (PFSF) Commences Work on Blockchain B2B/B2C eCommerce Platform in Support of International Trade
- CryptoNewsBreaks – Pacific Software, Inc. (PFSF) Inks Definitive Agreement to Commence Construction of E-Commerce Trade Platform
- CryptoNewsBreaks – Pacific Software, Inc. (PFSF) Inks LOI with Brazilian Nut Exporter
Earth Science Tech, Inc. (OTC: ETST)
Earth Science Tech, Inc. (OTC: ETST) is testing in Canada and Brazil a diverse mix of cannabidiol (CBD) formulations, including a superfood formula (http://nnw.fm/0gc1E). It is also conducting pre-launch lab studies of a medical device scheduled to be marketed internationally (http://nnw.fm/g4vqP).
Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.764005, off by 0.64%, on 1,515 volume with 7 trades. The average volume for the last 60 days is 10,302 and the stock's 52-week low/high is $0.324/$1.62.
- Earth Science Tech, Inc. (ETST) Pursues Multi-National Development of CBD Formulations, Hemp-Based Superfood and Home Testing Kit
- CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) is a Chocolatier of Full Spectrum, Flavored Cannabinoid Products
- Earth Science Tech, Inc. (ETST) Thinking of the Future in the CBD Space
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF)
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: ABCCF) (“VIVO” or the “Company”) is pleased to announce the appointment of Joel Mallard as the Company's Chief Customer Officer (CCO). Mr. Mallard will assume the position effective August 20, 2018 and will be tasked with building and leading VIVO’s sales teams and sales strategy across all markets.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (ABCCF), closed the day's trading session at $0.92, off by 4.17%, on 272,463 volume with 262 trades. The average volume for the last 60 days is 216,546 and the stock's 52-week low/high is $0.6574/$3.2929.
- VIVO Cannabis Appoints Chief Customer Officer
- REISSUE - ABcann Global Announces Company Name Change to VIVO Cannabis™
- ABcann Introduces Lumina, a Cannabis Brand Focused on Wellness
Cannabis Strategic Ventures, Inc. (OTC: NUGS)
Pure Applied Sciences, a wholly own subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), begins production of Halo Filters. Halo Filters is the company's patent pending, cannabis smoke filtration pre-roll cone. It is based on an internally developed filtering technology that utilizes ultra-high quality fibers and proprietary manufacturing methodologies. Halo Filters reduces the harsh taste in cannabis smoke and reduces the levels of harmful chemicals, heavy metals and other toxins, while maintaining optimum taste and cannabinoid levels.
Cannabis Strategic Ventures, Inc. (OTC: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.54, off by 6.67%, on 39,445 volume with 78 trades. The average volume for the last 60 days is 26,898 and the stock's 52-week low/high is $0.031/$7.13.
- Cannabis Strategic Ventures, Inc. Begins Production of Cannabis Filtration Device, Halo Filters
- CryptoNewsAudio Announces Audio Press Release (APR) on Virtual Crypto Technologies Inc. Bridging the Crypto Gap with NetoBit ATMs
- NetworkNewsWire Announces Publication on Cryptocurrency Seeking ATM Route to Mainstream Adoption
Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
Petroteq Energy (TSX.V: PQE) (OTCQX: PQEFF) was recently covered in a front-page article by the Vernal Express, a local newspaper in Vernal, Utah, near the company’s Asphalt Ridge facility. To view the full article, visit: http://nnw.fm/cJfO3.
Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.
PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.
The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.26, off by 9.35%, on 544,588 volume with 519 trades. The average volume for the last 60 days is 338,067 and the stock's 52-week low/high is $0.28/$1.8892.
- NetworkNewsBreaks – Petroteq Energy Inc.’s (TSX.V: PQE) (OTCQX: PQEFF) Asphalt Ridge Facility and Operations Well-received by Local Community
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Concludes Continuity Testing at Oil Extraction Facility in Utah
- Petroteq Completes Continuity Testing of New Plant
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Accelerated Technologies Holding Corp. (OTC: ATHC) Discusses Fintech Innovation in Exclusive NetworkNewsWire Interview
- Aftermaster, Inc. (OTCQB: AFTM) to Host Shareholder Update Call on August 21, 2018
- American Helium (TSX.V: AHE) (OTC: AHELF) Provides Shareholder Update
- Auscrete Corp. (OTC: ASCK) Setting Up New Production Plant in Ontario with Canadian Investment Group
- BLOCKStrain Technology Corp. (TSXV: DNAX) Opening Floodgates for Pending Launch of Disruptive Platform
- Cannabis Strategic Ventures, Inc. (OTC: NUGS) Begins Production of Cannabis Filtration Device, Halo Filters
- Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Developing a Presence in the Canadian Cannabis Market, Aurora Investment
- ChineseInvestors.com (OTCQB: CIIX) Subsidiary to Host Seminar on the Health Benefits of Hemp Oil
- Consorteum Holdings, Inc. (OTC: CSRH) Targets Rising Online and Mobile Gaming Market
- CytoDyn Inc. (CYDY) Appoints Michael A. Klump to Board of Directors
- DeepMarkit Inc. (TSX.V: MKT) (OTCQB: MKTDF) Gleans Analytics Data from Gamification Strategy to Offer Superior Marketing Tool
- DPW Holdings, Inc. (NYSE American: DPW) Subsidiary Receives $2M Supplemental Order from U.S. Defense Contractor
- Earth Science Tech, Inc. (OTC: ETST) Pursues Multi-National Development of CBD Formulations, Hemp-Based Superfood and Home Testing Kit
- FANDOM SPORTS Media (CSE:FDM) (OTC:FDMSF) (FRANKFURT:TQ42) Allows Sports Fans to Unleash Their Primal Sports Passions
- FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1.25M Capital Tranche to Refined Resin Technologies
- First Cobalt Corp. (TSX.V:FCC) (OTCQX:FTSSF) at the Forefront to Power New Age of EVs and Devices
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) NetworkNewsAudio Announces Audio Press Release (APR) on Foresight Autonomous Holdings Facing Extreme Weather Challenge with Better Vision than the Human Eye
- Global Payout, Inc. (OTC: GOHE) Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA
- GreenBox POS, LLC (OTCQB: GRBX) GreenBox POS Acquires Sky Technologies, Begins Onboarding of Over a $1B Book of Business
- GTX Corp (OTC: GTXO) Tracking Technology Selected By George Mason University Grant for Study to Predict Wandering
- Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR) and 1stPoint Communications, Endstream Communications and Open Data Centers Renew Letter of Intent
- Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) New Merger Agreement with Canopy Growth and Potential Synergies
- Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) Launches New Products, Expands Distribution & Begins Clinical Trials in the Functional Food & Beverage Space - CFN Media
- Lexaria Bioscience Corp. (CSE: LXX)(OTCQB: LXRP) Human Clinical Study on TurboCBD Capsules Corroborates Earlier DehydraTECH Test Results
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Ollague Property Displays Encouraging Traits
- Marijuana Company of America Inc. (OTC: MCOA) Holds Diverse Portfolio of Business Segments
- Medical Cannabis Payment Solutions (OTC: REFG) Positioning for Opportunity in Markets Expecting Double-Digit Growth
- Net Element, Inc. (NASDAQ: NETE) Unified Payments Launches Subscription-Based Payment Processing Services for Small Businesses
- NUGL Inc. (OTC: NUGL) Expands Revolutionary Cannabis Platform
- Pacific Software, Inc. (OTC: PFSF) Commences Work on Blockchain B2B/B2C eCommerce Platform in Support of International Trade
- Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is “One to Watch”
- Petroteq Energy Inc. (TSX.V:PQE) (OTC:PQEFF) Asphalt Ridge Facility and Operations Well-received by Local Community
- Pressure BioSciences Inc. (OTCQB: PBIO) to Discuss Second Quarter 2018 Financial Results and Provide Business Update
- PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) is Named for its Attention to Preventative Health Care
- QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF) Continues to Increase its Mineral Claim Holdings in Manitoba
- Sharing Services, Inc. (OTC: SHRV) Names Award-Winning Network Marketer Keith Halls as President and Chief Operating Officer of Elepreneur
- SinglePoint, Inc. (OTCQB: SING) CEO Discusses Future Acquisition Strategy in Interview on MoneyTV
- Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) to Provide Ultra-Purified Cannabis Extracts Through White Label Agreement
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Enters Agreement with E-Commerce Leader Shopify Inc. (NYSE: SHOP) (TSX: SHOP)
- TMSR Holding Company Ltd. (NASDAQ: TMSR) working with NetworkNewsWire
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) Appoints Chief Customer Officer
- Virtual Crypto Technologies Inc. (OTCQB: VRCP) CryptoNewsAudio Announces Audio Press Release (APR) on Virtual Crypto Technologies Inc. Bridging the Crypto Gap with NetoBit ATMs
- WhereverTV Broadcasting Corp. (TVTV) NetworkNewsWire Releases Exclusive Audio Interview
- Zenergy Brands, Inc. (OTC: ZNGY) Secures Zero Cost Contract with Popular Fast Food Chain
- Zenosense, Inc. (OTCQB: ZENO) Transforming Modern Cardiac Diagnostics
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.